YCFM (Youth Correctional Facilities Males)
Chlamydial Infection
About this trial
This is an interventional treatment trial for Chlamydial Infection focused on measuring Azithromycin, Chlamydia, Correctional, Facilities, Symptoms, Urethral, Urogenital, Youth
Eligibility Criteria
Inclusion Criteria:
1.Male between the ages of 12 and 21 years 2.Residing in a long-term gender-segregated (no co-ed) YCF 3.Diagnosed with urogenital chlamydia as determined by a screening C. trachomatis NAAT 4.Anticipated length of stay at the YCF at the time of enrollment is at least 28 days 5.Willingness to provide written consent 6.Willingness to comply with study procedures
Exclusion Criteria:
1.Diagnosed with gonorrhea as determined by a screening Neisseria gonorrhoeae NAAT 2.Clinical diagnosis of epididymitis based on review of medical records 3.Known allergy to azithromycin, erythromycin, any macrolide or ketolide drug 4.History of liver problems due to use of azithromycin 5.Having received antimicrobial therapy with activity against C. trachomatis within 21 days of the positive chlamydia screening NAAT or in the interval between the positive screening NAAT and study enrollment 6.Any concomitant infection, which requires antimicrobial therapy with activity against C. trachomatis 7.Previously enrolled in this study 8.Unable to swallow pills 9.Other exclusion criteria, per clinician judgment, that prohibits subject from enrolling in study
Sites / Locations
- Los Angeles County Department of Health Services - Juvenile Court Health Services
Arms of the Study
Arm 1
Experimental
Azithromycin
Azithromycin 1 gm PO single dose given as directly observed